(Q40586552)

21 September 2017

1 reference

title

Rheumatoid arthritis and osteoarthritis: current and future therapies (English)

1 reference

21 September 2017

1 reference

Flynn BL

1

1 reference

21 September 2017

1 November 1994

1 reference

21 September 2017

1 reference

21 September 2017

NS34

1 reference

21 September 2017

11

1 reference

21 September 2017

31-7, 41-2

1 reference

Symptomatic salicylate ototoxicity: a useful indicator of serum salicylate concentration?

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

Drug treatment of arthritis. Update on conventional and less conventional methods

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

Intranasal calcitonin for the prevention of bone erosion and bone loss in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

Osteoarthritis treatment update. Minimizing pain while limiting patient risk

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0160-3450%2815%2930253-1

7 January 2021

10.1016/S0160-3450(15)30253-1

Identifiers

DOI

0 references

PubMed ID

7847244

1 reference

PubMed ID

7847244